New preprint: predicting rifampicin resistance Philip Fowler, 16th August 202416th August 2024 In this preprint we train a series of machine learning models on protein mutations found in rpoB — this is the gene in the M. tuberculosis RNA polymerase complex where mutations can introduce resistance to rifampicin, an important first-line drug in the treatment of tuberculosis. Unlike pyrazinamide, which we have previously published and binds to pncA, the RNA polymerase is an essential gene and therefore resistance-conferring mutations tend to be subtle and, in this case, mostly close to the rifampicin binding site. We find that all the models achieve similar levels of prediction performance and that the most predictive feature is, perhaps unsurprisingly, the distance from the amino acid being mutated to the centre of mass of rifampicin. All the data and code required to create our Test+Train datasets, train the models and produce nearly all the figures in the preprint is available on GitHub. Share this:Twitter Related antimicrobial resistance computing publication research tuberculosis
publication New publication: Nothing to Sneeze At – A Dynamic and Integrative Computational Model of an Influenza A Virion 6th March 2015 In this paper we show how we built and then simulated a model of the… Share this:Twitter Read More
computing HackDay: Data on Acid 31st March 2015 Every year the Software Sustainability Institute (SSI) run a brilliant meeting called the Collaborations Workshop,… Share this:Twitter Read More
computing Is Software a Method? 1st April 201523rd September 2018 Last month I went to the Annual Meeting of the US Biophysical Society. As a… Share this:Twitter Read More